Researchers have found that a cancer outside the brain makes electrical connections with the nervous system to fuel cancer growth and aid its spread.

Imagion Biosystems has initiated manufacturing of its MagSense imaging agent for its phase II clinical study on HER2+ breast ...

A research team led by Professor Kevin Tsia, program director of the Biomedical Engineering Program under the Faculty of Engineering of the University of Hong Kong (HKU), has developed an AI-driven ...

Empa researchers have developed a new 3D tissue analysis for thyroid tumors. This special X-ray technique uses artificial ...

The CytoMAD tool leverages microfluidic technology for 'label-free' imaging, allowing clinicians to examine tumour cells.

Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Bernstam, MD, discusses updated findings from the phase 1 TROPION-PanTumor01 study of datopotamab deruxtecan-dlnk in heavily ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Contrast-enhanced conebeam breast CT imaging features can help identify lymphovascular invasion status in patients with ...

According to Runcie C.W. Chidebe, a cancer advocate, and executive director of Project PINK BLUE, countries in North Africa have an extensive number of PET-CT scanners and a well-developed nuclear ...

The mission of this group is to investigate innovative imaging probes and apply them to novel orthotopic or metastatic models that are target driven, to gain information of the way particular ...